Capital World Investors Allogene Therapeutics, Inc. Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Capital World Investors holds 6,896,552 shares of ALLO stock, worth $15.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,896,552

Previous 6,896,552 -0.0%

Holding current value

$15.7 Million

Previous $16.1 Million 20.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.23 - $4.38 $15.4 Million - $30.2 Million	6,896,552 New	6,896,552 $16.1 Million
Q1 2022 May 16, 2022	SELL	$7.65 - $15.29 $9.95 Million - $19.9 Million	-1,300,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $12.4 Million - $23.2 Million	-946,576 Reduced 42.13%	1,300,000 $19.4 Million
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $21 - $27	-1 Reduced -0.0%	2,246,576 $57.7 Million
Q2 2021 Aug 16, 2021	SELL	$23.49 - $35.8 $610 - $930	-26 Reduced -0.0%	2,246,577 $58.6 Million
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $3.23 Million - $4.89 Million	-125,214 Reduced 5.28%	2,246,603 $79.3 Million
Q4 2020 Feb 12, 2021	SELL	$25.24 - $43.45 $7.42 Million - $12.8 Million	-293,869 Reduced 11.02%	2,371,817 $59.9 Million
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $26.4 Million - $36.7 Million	-815,438 Reduced 23.42%	2,665,686 $101 Million
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $9.26 Million - $27.2 Million	503,460 Added 16.91%	3,481,124 $149 Million
Q4 2019 Feb 18, 2020	SELL	$24.82 - $31.4 $7.4 Million - $9.36 Million	-298,021 Reduced 9.1%	2,977,664 $77.4 Million
Q3 2019 Nov 14, 2019	BUY	$26.11 - $32.99 $13.1 Million - $16.5 Million	501,104 Added 18.06%	3,275,685 $89.3 Million
Q2 2019 Aug 14, 2019	BUY	$25.56 - $31.09 $15.4 Million - $18.8 Million	603,098 Added 27.77%	2,774,581 $74.5 Million
Q4 2018 Feb 14, 2019	BUY	$22.5 - $33.3 $48.9 Million - $72.3 Million	2,171,483 New	2,171,483 $58.5 Million

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Allogene Therapeutics, Inc. Transaction History